GlassScriptPhysician profile
Andrew Green
NPI 1598787988
$7,111.39
in general payments reported to CMS, 2019-2025
41 companies · $2,475 in 2025
The $2,475 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2020: $232 · 2021: $849 · 2022: $272 · 2023: $1,319 · 2024: $1,508 · 2025: $2,475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,575 · Travel and Lodging: $678 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,574.95 |
| Travel and Lodging | $677.70 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,445.27 | 2021-2025 | |
| Stryker Corporation | $1,130.93 | 2021-2025 | Augment Injectable, Infinity Adaptis, Easyfuse |
| Smith+Nephew, INC. | $801.02 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix |
| Linvatec Corporation | $586.42 | 2023-2025 | Biobrace 23mm, 5ms, Colink 2 |
| Amgen INC. | $463.89 | 2024-2025 | Krystexxa |
| Acera Surgical, INC. | $453.19 | 2022-2025 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $363.81 | 2019-2023 | Krystexxa |
| Integra Lifesciences Corporation | $223.77 | 2019-2025 | Tcc-Ez, Integra, Integra Dermal Regeneration Template |
| Sanara Medtech INC. | $174.90 | 2023 | Celleraterx |
| Organogenesis INC. | $123.24 | 2019-2025 | Puraply, Puraply Wound Matrix |
| Biotissue Holdings INC. | $96.64 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $92.02 | 2019 | |
| Next Science LLC | $86.59 | 2023-2024 | Xperience, Blastx, Surgx |
| Solventum Corporation | $85.98 | 2024 | V.A.C. Veraflo |
| Kerecis Limited | $77.76 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $77.40 | 2023-2024 | Qutenza |
| Boston Scientific Corporation | $70.61 | 2024-2025 | General - Pain Management |
| Aroa Biosurgery Incorporated | $67.77 | 2024-2025 | |
| Amniox Medical, INC. | $63.42 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $60.22 | 2024-2025 | Nuzyra |
| Pfizer INC. | $53.82 | 2019-2020 | |
| Orthofix Medical, INC. | $51.48 | 2020-2025 | Physio-Stim |
| Medtronic, INC. | $49.05 | 2023-2024 | Intellis Adaptivestim |
| Reprise Biomedical, INC. | $45.57 | 2022-2025 | Miro3d |
| Depuy Synthes Sales INC. | $37.79 | 2019 | |
| Abbott Laboratories | $36.06 | 2020-2025 | Eterna |
| Axogen | $32.15 | 2021 | |
| Convatec INC. | $25.64 | 2024 | |
| Avita Medical Americas, LLC | $23.60 | 2025 | Permeaderm, Recell, Cohealyx |
| Cardiovascular Systems INC. | $22.53 | 2022 | |
| Osiris Therapeutics INC. | $21.47 | 2019 | |
| Globus Medical, INC. | $20.87 | 2025 | Senza |
| Kci USA, INC. | $20.72 | 2023 | V.A.C. Veraflo Cleanse Choice |
| Mimedx Group, INC. | $19.82 | 2025 | |
| Cashflow Solutions, LLC | $19.16 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Wright Medical Technology, INC. | $18.19 | 2020 | |
| Melinta Therapeutics, LLC | $17.24 | 2019 | |
| Hydrocision, INC. | $14.17 | 2024 | Tenjet |
| Advanced Oxygen Therapy INC. | $13.64 | 2024 | Topical Oxygen Chamber For Extremities |
| Bioventus LLC | $12.41 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $11.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.